Deep knowledge on
small-molecule drugs and
the 90,000 global patents
|Title:||Tableting of colestipol hydrochloride|
|Abstract:||The present invention provides a novel formulation of matter and a novel process for making it. In particular, the present invention provides unique and novel 1000 mg tablets of Colestipol hydrochloride having the advantageous properties of hardness and low friability and a novel process for making such tablets.|
|Inventor(s):||Shen; Robert W. (Kalamazoo, MI), Price; Jeffrey E. (Schoolcraft, MI)|
|Assignee:||The Upjohn Company (Kalamazoo, MI)|
Patent Claim Types:|
see list of patent claims
|Compound; Dosage form; Process;|
|PCT Filed||June 23, 1992||PCT Application Number:||PCT/US92/05066|
|PCT Publication Date:||January 21, 1993||PCT Publication Number:||WO93/00915|
|Country||Document Number||Publication Date||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Spain||2124736||Feb 16, 1999|
|Canada||2110166||Jan 21, 1993|
|European Patent Office||0592594||Dec 02, 1998|
|Austria||173931||Dec 15, 1998|
|World Intellectual Property Organization (WIPO)||9300915||Jan 21, 1993|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.